Drug Shortage Report for NOVAHISTEX DH

Last updated on 2018-05-08 History
Report ID 41428
Drug Identification Number 02049481
Brand name NOVAHISTEX DH
Common or Proper name Novahistex DH 100ml
Company Name SANOFI-AVENTIS CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) PHENYLEPHRINE HYDROCHLORIDE HYDROCODONE BITARTRATE
Strength(s) 20MG 5MG
Dosage form(s) SYRUP
Route of administration ORAL
Packaging size 100ml
ATC code R05DA
ATC description COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2018-03-21
Actual start date
Estimated end date 2018-05-16
Actual end date 2018-05-07
Shortage status Resolved
Updated date 2018-05-08
Company comments
Health Canada comments
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-03-01 English Compare
v2 2018-03-01 French Compare
v3 2018-03-15 English Compare
v4 2018-03-15 French Compare
v5 2018-03-22 English Compare
v6 2018-04-04 English Compare
v7 2018-04-04 French Compare
v8 2018-05-07 English Compare
v9 2018-05-08 English Compare
v10 2018-05-08 French Compare